Can Micro RNA-۲۴ Affect the Cardiovascular Morbidity in Systemic Lupus Erythematosus by Targeting YKL-۴۰?
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 183
This Paper With 13 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RBMB-11-3_019
تاریخ نمایه سازی: 18 دی 1401
Abstract:
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with inflammatory nature. One of the leading causes of death in SLE patients is cardiovascular (CVS) morbidity. MiRNA-۲۴ is highly expressed in vascular endothelial cells (VECs). This dysregulated expression pattern is associated with dysfunction or even damage of VECs and leads to the occurrence of cardiovascular diseases. YKL- ۴۰ is an inflammatory glycoprotein involved in the pathogenesis of endothelial dysfunction and thereby atherosclerosis. In this work, we aimed at illustrating the possible role of miR-۲۴ and its target YKL-۴۰ in the pathogenesis of the CVS morbidity associated with SLE.
Methods: This work was conducted on ۴۰ SLE patients and ۴۰ healthy controls. Quantitative realtime PCR (qPCR) was done to estimate the expression level of miRNA-۲۴ in serum. In addition, we measured the serum level of YKL-۴۰ using ELISA.
Results: miR-۲۴-fold change was found to be down-regulated, whereas serum YKL- ۴۰ was upregulated among SLE patients with observed significant and negative correlation between the two parameters.
Conclusions: Our study provided an insight about the role of miR-۲۴ and its target serum YKL-۴۰ protein in the development of SLE-related inflammation and atherosclerosis.
Authors
Maha Alhelf
Biotechnology School, Nile University, Giza, Egypt.
Laila Rashed
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University,Cairo, Egypt.
Sahar Ahmed
Rheumatologyand Immunology Unit, Internal Medicine Department, Faculty ofMedicine, Cairo University, Cairo, Egypt.
Mohamed Mohamed
Endocrinology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Marwa Abdelgwad
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University,Cairo, Egypt.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :